190 related articles for article (PubMed ID: 12942120)
21. Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.
Koda M; Kanczuga-Koda L; Sulkowska M; Surmacz E; Sulkowski S
BMC Cancer; 2010 Jun; 10():320. PubMed ID: 20569445
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer.
Havelund BM; Sørensen FB; Lindebjerg J; Spindler KL; Jakobsen A
Anticancer Res; 2011 May; 31(5):1559-65. PubMed ID: 21617210
[TBL] [Abstract][Full Text] [Related]
23. Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.
Zhou S; Wang S; Wu Q; Fan J; Wang Q
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):189-94. PubMed ID: 18401196
[TBL] [Abstract][Full Text] [Related]
24. Expression of GLUT-1 in nasopharyngeal carcinoma and its clinical significance.
Zhou JC; Zhang JJ; Zhang W; Ke ZY; Ma LG; Liu M
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4891-4895. PubMed ID: 29164572
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance of p53, p21, and p27 expressions in rectal carcinoma.
Lebe B; Sarioğlu S; Sökmen S; Ellidokuz H; Füzün M; Küpelioğlu A
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):38-44. PubMed ID: 15722792
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.
García VM; Batlle JF; Casado E; Burgos E; de Castro J; Belda C; Barriuso J; Sánchez JJ; García-Cabezas MÁ; González-Barón M; Cejas P
Colorectal Dis; 2011 Sep; 13(9):989-98. PubMed ID: 20718834
[TBL] [Abstract][Full Text] [Related]
27. Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer.
Wang Q; Chen ZG; Du CZ; Wang HW; Yan L; Gu J
Histopathology; 2009 Sep; 55(3):284-93. PubMed ID: 19723143
[TBL] [Abstract][Full Text] [Related]
28. Membranous expression of glucose transporter-1 protein (GLUT-1) in embryonal neoplasms of the central nervous system.
Loda M; Xu X; Pession A; Vortmeyer A; Giangaspero F
Neuropathol Appl Neurobiol; 2000 Feb; 26(1):91-7. PubMed ID: 10736070
[TBL] [Abstract][Full Text] [Related]
29. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
[TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma.
Deron P; Vermeersch H; Mees G; Vangestel C; Pauwels P; Van de Wiele C
Histol Histopathol; 2011 Sep; 26(9):1165-72. PubMed ID: 21751148
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy.
Lee-Kong SA; Ruby JA; Chessin DB; Pucciarelli S; Shia J; Riedel ER; Nitti D; Guillem JG
Dis Colon Rectum; 2012 Sep; 55(9):990-5. PubMed ID: 22874607
[TBL] [Abstract][Full Text] [Related]
32. The local immune phenotype influences prognosis in patients with nodal-positive rectal cancer after neoadjuvant chemoradiation.
Schollbach J; Kircher S; Wiegering A; Anger F; Rosenwald A; Germer CT; Löb S
Int J Colorectal Dis; 2020 Feb; 35(2):365-370. PubMed ID: 31828368
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma.
Ogane N; Yasuda M; Shimizu M; Miyazawa M; Kamoshida S; Ueda A; Takata K; Sakuma Y; Miyagi Y; Kameda Y
Ann Diagn Pathol; 2010 Feb; 14(1):23-9. PubMed ID: 20123453
[TBL] [Abstract][Full Text] [Related]
34. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Chikamoto A; Inoue R; Komohara Y; Sakamaki K; Hashimoto D; Shiraishi S; Takamori H; Yamashita YI; Yoshida N; Yamanaka T; Yamashita Y; Baba H
Ann Surg Oncol; 2017 Jul; 24(7):2040-2046. PubMed ID: 28180987
[TBL] [Abstract][Full Text] [Related]
35. Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers.
Mayer A; Höckel M; Wree A; Vaupel P
Clin Cancer Res; 2005 Apr; 11(7):2768-73. PubMed ID: 15814659
[TBL] [Abstract][Full Text] [Related]
36. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.
Brown RS; Wahl RL
Cancer; 1993 Nov; 72(10):2979-85. PubMed ID: 8221565
[TBL] [Abstract][Full Text] [Related]
38. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck.
Reisser C; Eichhorn K; Herold-Mende C; Born AI; Bannasch P
Int J Cancer; 1999 Jan; 80(2):194-8. PubMed ID: 9935199
[TBL] [Abstract][Full Text] [Related]
39. Variability in glucose transporter-1 levels and hexokinase activity in human melanoma.
Wachsberger PR; Gressen EL; Bhala A; Bobyock SB; Storck C; Coss RA; Berd D; Leeper DB
Melanoma Res; 2002 Feb; 12(1):35-43. PubMed ID: 11828256
[TBL] [Abstract][Full Text] [Related]
40. Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.
Schlößer HA; Drebber U; Urbanski A; Haase S; Baltin C; Berlth F; Neiß S; von Bergwelt-Baildon M; Fetzner UK; Warnecke-Eberz U; Bollschweiler E; Hölscher AH; Mönig SP; Alakus H
Gastric Cancer; 2017 Jan; 20(1):83-91. PubMed ID: 26643879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
